ISPE‘s Facility of the Year Awards

Boehringer_DE_2021_BI SOL SolidLaunchFacility_4861_T
Centocor (Johnson & Johnson)
Switzerland
New R&D fill finish pilot plant
Facility of the year Award 2009 –
Facility Integration
Boehringer_DE_2021_BI SOL SolidLaunchFacility_4861_T
Novo Nordisk AS
Denmark
Construction of the NovoSeven® Facility
Facility of the year Award 2005 –
Life-saving drug NovoSeven®

Historische CAPEX-Projekte von Pharmaplan

1981

Hemofarm, Serbia

Pharmaplan extended its know-how to dialyzer and blood tubing systems. Construction of a production plant for dialyzers and blood tubing systems at Hemomed.

1981

Hemofarm, Serbia

Pharmaplan extended its know-how to dialyzer and blood tubing systems. Construction of a production plant for dialyzers and blood tubing systems at Hemomed.

1981

Hemofarm, Serbia

Pharmaplan extended its know-how to dialyzer and blood tubing systems. Construction of a production plant for dialyzers and blood tubing systems at Hemomed.

Partnerships

Boehringer_DE_2021_BI SOL SolidLaunchFacility_4861_T
Project
New ATMP facility
Technology
ATMP
Location
Germany
Customer
Confidential
Duration
2020 - origoing
TIC
Confidential
Scope
EPCMV
Project Description
New facility for the production of individual specific therapies. Production of individualized vaccines for several thousand patients per car for both clinical phases and commercial production.
S10-unter Testi Stefan Filz_0d115bf8-18fb-4ca5-8c36-5c5e734f0dfa
Project
New ATMP facility
Technology
ATM
Location
Germany
Customer
Confidential
Duration
2020 - origoing
TIC
Confidential
Scope
EPCMV
Project Description
New facility for the production of individual specific therapies. Production of individualized vaccines for several thousand patients per car for both clinical phases and commercial production.
Boehringer_DE_2021_BI SOL SolidLaunchFacility_4861_T
Project
New ATMP facility
Technology
ATMP
Location
Germany
Customer
Confidential
Duration
2020 - origoing
TIC
Confidential
Scope
EPCMV
Project Description
New facility for the production of individual specific therapies. Production of individualized vaccines for several thousand patients per car for both clinical phases and commercial production.